State-of-the-Art FDG-PET imaging of lung cancer.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Seminars in roentgenology

• Publication date

  2005-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/J.RO.2005.01.008PMID 15898411
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Non-small cell lung cancer: Clinical practice guidelines in oncology

  2006cited by this paper
• Lipomatous hypertrophy of the interatrial septum: increased uptake on FDG PET.

  2005cited by this paper
• Les cancers bronchiques primitifs faussement négatifs en tomographie par émission de positrons ont habituellement un bon pronostic

  2005cited by this paper
• Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging.

  2004cited by this paper
• Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis.

  2004cited by this paper
• False-positive FDG positron emission tomography uptake in nonmalignant chest abnormalities.

  2004cited by this paper
• False-negative findings for primary lung tumors on FDG positron emission tomography: staging and prognostic implications.

  2004cited by this paper
• False-Positive PET Scan in a Patient With Lipoid Pneumonia Simulating Lung Cancer

  2004cited by this paper
• Diffuse FDG uptake in the lungs in aspiration pneumonia on positron emission tomographic imaging.

  2004cited by this paper
• Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.

  2004cited by this paper
• Lung cancer staging.

  2004cited by this paper
• Improved Radiologic Staging of Lung Cancer with 2-[18F]-Fluoro-2-Deoxy-d-Glucose–Positron Emission Tomography and Computed Tomography Registration

  2003cited by this paper
• Non-small cell lung cancer: dual-modality PET/CT in preoperative staging.

  2003cited by this paper
• Talc Pleurodesis Mimics Pleural Metastases: Differentiation With Positron Emission Tomography/Computed Tomography

  2003cited by this paper
• Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG.

  2003cited by this paper
• Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

  2003cited by this paper
• Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET.

  2003cited by this paper
• Advantages of positron emission tomography over computed tomography in mediastinal staging of non-small cell lung cancer.

  2002cited by this paper
• Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography

  2002cited by this paper
• Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region

  2002cited by this paper
• Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion.

  2002cited by this paper
• Dual time point 18F-FDG PET for the evaluation of pulmonary nodules.

  2002cited by this paper
• FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models.

  2001cited by this paper
• Benign mediastinal lymphadenopathy in congestive heart failure.

  2001cited by this paper
• Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis.

  2001cited by this paper
• Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes.

  2001cited by this paper
• F-18 fluorodeoxyglucose chest uptake in lung inflammation and infection.

  2000cited by this paper
• Preoperative staging of non-small-cell lung cancer with positron-emission tomography.

  2000cited by this paper
• FDG PET of pleural effusions in patients with non-small cell lung cancer.

  2000cited by this paper
• Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small ( 3 cm) lymph node lesions.

  2000cited by this paper
• Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases.

  2000cited by this paper
• Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions.

  2000cited by this paper
• Incidental Detection of Thoracic Sarcoidosis on Whole-Body 18Fluorine-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography

  2000cited by this paper
• FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features.

  2000cited by this paper
• Clinical and surgical staging of non-small cell lung cancer.

  2000cited by this paper
• Uptake of positron emission tomography tracers in experimental bacterial infections: a comparative biodistribution study of radiolabeled FDG, thymidine, l-methionine, 67Ga-citrate, and 125I-HSA

  1999cited by this paper
• Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer.

  1999cited by this paper
• FDG imaging of lung nodules: a phantom study comparing SPECT, camera-based PET, and dedicated PET.

  1999cited by this paper
• Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer.

  1999cited by this paper
• Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT.

  1999cited by this paper
• Staging non-small cell lung cancer with whole-body PET.

  1999cited by this paper
• Prospective investigation of positron emission tomography in lung nodules.

  1998cited by this paper
• Evaluation of primary pulmonary carcinoid tumors using FDG PET.

  1998cited by this paper
• FDG uptake, tumour characteristics and response to therapy: A review

  1998cited by this paper
• Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer

  1998cited by this paper
• Localized form of bronchioloalveolar carcinoma: FDG PET findings.

  1998cited by this paper
• Mediastinal lymphadenopathy and hazy mediastinal fat: new CT findings of congestive heart failure.

  1998cited by this paper
• Thoracic FDG PET: state of the art.

  1998cited by this paper
• Fluorine-18-fluorodeoxyglucose uptake in pneumonia.

  1998cited by this paper
• Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.

  1997cited by this paper
• Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer.

  1997cited by this paper
• Revisions in the International System for Staging Lung Cancer.

  1997cited by this paper
• Comparison of positron emission tomography and computed tomography in the mediastinal and extrathoracic staging of non-small cell lung cancer

  1996cited by this paper
• FDG-PET in infectious lesions: The detection and assessment of lesion activity

  1996cited by this paper
• Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.

  1996cited by this paper
• Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings.

  1996cited by this paper
• The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography

  1996cited by this paper
• Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy.

  1996cited by this paper
• Lung cancer staging: the value of ipsilateral scalene lymph node biopsy performed at mediastinoscopy.

  1996cited by this paper
• Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.

  1995cited by this paper
• Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy.

  1995cited by this paper
• High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue.

  1995cited by this paper
• Staging non-small cell lung cancer by whole-body positron emission tomographic imaging.

  1995cited by this paper
• Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma.

  1995cited by this paper
• Mediastinal staging of non-small-cell lung cancer with positron emission tomography.

  1995cited by this paper
• SUV: standard uptake or silly useless value?

  1995cited by this paper
• Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose.

  1994cited by this paper
• Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose

  1994cited by this paper
• Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose. The Members of the PET-Lung Tumor Study Group.

  1994cited by this paper
• Pleural exudates and transudates: diagnosis with contrast-enhanced CT.

  1994cited by this paper
• Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.

  1993cited by this paper
• Metabolic regulation of glucose transport

  1993cited by this paper
• Growth factors, mitogens, oncogenes and the regulation of glucose transport.

  1993cited by this paper
• In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy.

  1993cited by this paper
• Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction.

  1993cited by this paper
• Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling.

  1992cited by this paper
• Lipomatous Hypertrophy of the Interatrial Septum

  1992cited by this paper
• Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy.

  1988cited by this paper
• METABOLIC TRAPPING AS A PRINCIPLE OF RADIO-PHARMACEUTICAL DESIGN: SOME FACTORS RESPONSIBLE FOR THE BIODISTRIBUTION OF 18F-2-DEOXY-2-FLUORO-D-GLUCOSE

  1979cited by this paper
• Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method

  1979cited by this paper
• Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose.

  1978cited by this paper
• BROWN ADIPOSE TISSUE.

  1965cited by this paper

• In Vivo Visualization of Tumor Metabolic Activity with a Tetra Glucose-Conjugated Zinc-Phthalocyanine Photoacoustic Contrast

  2025cites this paper
• Nuclear Oncology

  2017cites this paper
• Fluorine-18 fluorodeoxyglucose positron emission tomography in the management of solitary pulmonary nodule: a review

  2017cites this paper
• Diagnostic Applications of Nuclear Medicine: Lung and Mediastinal Tumors

  2017cites this paper
• Diagnostic étiologique d’une condensation pulmonaire chronique : apport de l’imagerie

  2016cites this paper
• PET-CT in the sub-arctic region of Norway 2010–2013. At the edge of what is possible?

  2015cites this paper
• Lung and Mediastinal Tumors

  2013cites this paper
• [Role of imaging techniques in the TNM classification of non-small cell bronchogenic carcinoma].

  2012cites this paper
• [Role of imaging techniques in the TNM classification of non-small cell bronchogenic carcinoma].

  2012cites this paper
• Papel de las técnicas de imagen en la nueva clasificación TNM del carcinoma broncogénico no microcítico

  2012cites this paper
• Feasibility of shrinking field radiation therapy through 18F-FDG PET/CT after 40 Gy for stage III non-small cell lung cancers.

  2012cites this paper
• Non-small cell lung cancer (NSCLC): Review of the seventh edition of the TNM staging system and role of imaging in the staging and follow-up of NSCLC.

  2011cites this paper
• Multiplexed imaging in cancer diagnosis: applications and future advances.

  2010cites this paper
• Interobserver Variability in Chest CT and Whole Body FDG-PET Screening for Distant Metastases in Head and Neck Cancer Patients

  2010cites this paper
• FDG-PET/CT in lung cancer: an update.

  2010cites this paper
• Selection of sublobar resection for c-stage IA non-small cell lung cancer based on a combination of structural imaging by CT and functional imaging by FDG PET.

  2009cites this paper
• Role of Integrated PET/CT Fusion in Lung Carcinoma.

  2008cites this paper
• Integrated positron emission tomography/computed tomography fusion imaging: an emerging gold standard in lung cancer.

  2008cites this paper
• Feature Reduction in Graph Analysis

  2008cites this paper
• The Role of Imaging in Lung Cancer

  2008cites this paper
• [Usefulness of endobronchial ultrasonography with real-time needle aspiration for lung cancer staging].

  2007cites this paper
• Impact of PET on radiation therapy planning in lung cancer.

  2007cites this paper
• [Intrathoracic gossypiboma interpreted as bronchogenic carcinoma. Another false positive with positron emission tomography].

  2007cites this paper
• Integrated PET/CT in imaging of non-small cell lung cancer.

  2007cites this paper
• PET/CT in non-small cell lung cancer staging-promises and problems.

  2007cites this paper
• Simulation Monte Carlo de suivi de positrons dans la matière biologique : applications en imagerie médicale

  2007cites this paper
• Track structure simulation for positron emitters of medical interest. Part I: The case of the allowed decay isotopes

  2007cites this paper
• Improved non-invasive T-Staging in non-small cell lung cancer by integrated18F-FDG PET/CT

  2007cites this paper
• Positron follow-up in liquid water: II. Spatial and energetic study for the most important radioisotopes used in PET

  2007cites this paper
• Utilidad de la ultrasonografía endobronquial con punción-aspiración en tiempo real para la estadificación de la neoplasia broncopulmonar

  2007cites this paper
• PET/CT in non-small cell lung cancer staging - promises and problems

  2007cites this paper
• Textiloma intratorácico interpretado como carcinoma broncogénico. Otro falso positivo de la tomografía por emisión de positrones

  2007cites this paper
• Intrathoracic gossypiboma interpreted as bronchogenic carcinoma. Another false positive with positron emission tomography

  2007cites this paper
• Positron emission tomography: a false negative result in cystic encephalic mestastases from a small cell bronchial carcinoma

  2006cites this paper
• Preliminary results on the role of PET/CT in initial staging, restaging, and management of lung cancer

  2006cites this paper
• Impact of PET on Radiation Therapy Planning.

  2006cites this paper
• Pulmonary suture abscess with false-positive 18F-fluorodeoxyglucose positron emission scan mimicking lung cancer recurrence.

  2006cites this paper
• Biij Biomedical Imaging and Intervention Journal Incorporating Pet Information in Radiation Therapy Planning

  year unknowncites this paper